These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The antiphospholipid-thrombosis syndromes. Fact, fiction, confusion, and controversy. Bick RL. Am J Clin Pathol; 1993 Nov; 100(5):477-80. PubMed ID: 8249884 [Abstract] [Full Text] [Related]
9. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome]. Soltész P, Veres K, Kiss E, Lakos G, Sonkoly I, Muszbek L, Szegedi G. Orv Hetil; 2000 Dec 24; 141(52):2821-5. PubMed ID: 11202118 [Abstract] [Full Text] [Related]
15. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies. Sanmarco M, Gayet S, Alessi MC, Audrain M, de Maistre E, Gris JC, de Groot PG, Hachulla E, Harlé JR, Sié P, Boffa MC. Thromb Haemost; 2007 Jun 24; 97(6):949-54. PubMed ID: 17549297 [Abstract] [Full Text] [Related]
18. The antiphospholipid syndrome: when does the presence of antiphospholipid antibodies require therapy? Devine DV, Brigden ML. Postgrad Med; 1996 Jun 24; 99(6):105-8, 113-25. PubMed ID: 8668625 [Abstract] [Full Text] [Related]